New research demonstrates the value of genomic and epigenomic methylation sequencing capabilities of Predicine liquid biopsy platform for biomarker discovery,...
CHASKA, Minn., April 14, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received...
MOORESVILLE, N.C., April 14, 2023 (GLOBE NEWSWIRE) -- The Hemp Doctor, a leading provider of high-quality innovative products, is proud...
First clinical results to be presented at the AACR Annual Meeting 2023 showed 23ME-00610 demonstrated an acceptable safety and tolerability...
JENA, Germany, April 14, 2023 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a clinical-stage biopharmaceutical company developing anti-inflammatory...
NEW YORK and VIENNA, Austria, April 14, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, the “Company”), a company...
BEDFORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development,...
PETACH TIKVA, Israel, April 14, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming...
PLEASANTON, Calif., April 14, 2023 (GLOBE NEWSWIRE) -- InkSpace Imaging is pleased to announce the appointment of George Rehm, JD,...
KANSAS CITY, Kan., April 14, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision...
Regulated Information Leuven, BELGIUM, Boston, MA, US – April 14, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR)...
ISS, an independent, third-party proxy advisory firm, recommends Sernova’s shareholders vote FOR all management’s director nominees using ONLY management’s WHITE...
PetVivo Holdings, Inc. Spencer Breithaupt Joins PetVivo Holdings, Inc.MINNEAPOLIS, MN, US, April 14, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc....
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2023 (Pursuant to Article L.233-8 II of the...
- Data highlight favorable preclinical profiles for two chemically-distinct allosteric, oral small molecule KRAS inhibitors with potent anti-tumor activity -...
First-Quarter 2023 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure...
Two late-breaking abstracts will be presentedAU ZH, Switzerland, April 14, 2023 (GLOBE NEWSWIRE) -- Araris Biotech AG, a company pioneering...
STAMFORD, Conn., April 14, 2023 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit committed to helping America’s military veterans take their...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we,...
- Robust 36% overall response rate (ORR) in 42 evaluable patients - 6 months median duration of response with 17...